Related Experiment Videos
Insights from integrative spatial transcriptomics in sepsis-associated acute kidney injury
Moritz Uhlig1,2, David Schumacher1,2, Gernot Marx2,3
1Department of Nephrology and Clinical Immunology, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Nature Reviews. Nephrology
|July 28, 2026
Summary
Spatial transcriptomics reveals distinct cellular niches driving sepsis-associated acute kidney injury (SA-AKI). Understanding these microenvironments is key to developing targeted therapies and identifying prognostic biomarkers for SA-AKI.
Area of Science:
- Nephrology
- Molecular Biology
- Systems Biology
Background:
- Sepsis-associated acute kidney injury (SA-AKI) is a critical complication of sepsis with poorly understood pathophysiology.
- Existing molecular techniques like transcriptomics and proteomics lack spatial context for tissue analysis.
- Understanding SA-AKI's complex immune, vascular, and parenchymal interactions is vital for new treatments.
Purpose of the Study:
- To investigate the spatial architecture of septic kidneys using integrated multi-omics approaches.
- To identify specific cellular niches and their crosstalk contributing to SA-AKI.
- To uncover druggable pathways and potential clinical biomarkers for SA-AKI.
Main Methods:
- Integration of high-resolution spatial transcriptomics with single-cell RNA sequencing and other multi-omics data.
- Analysis of cellular and molecular heterogeneity within kidney tissue during SA-AKI.
- Localization of pathological signaling pathways and their transmission across different cell types.
Main Results:
- Identification of discrete inflammatory, vascular, and tubular niches contributing to SA-AKI.
- Spatial mapping of signaling crosstalk between immune, endothelial, and epithelial cells.
- Demonstration that niche-specific interactions impair kidney function even with mild global histological changes.
Conclusions:
- Integrative spatial transcriptomics provides a novel approach to dissect SA-AKI pathophysiology.
- Resolving niche-specific crosstalk can highlight therapeutic targets and biomarker candidates.
- This approach may lead to the identification of mechanistic endotypes for improved prognosis and clinical trial stratification.
Related Concept Videos
Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury II: Pathophysiology
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...